AbstractsPublication policy

Abstracts

Showing 10 of 70 abstracts

The immune-related mechanisms underpinning ACLF and its modulation by albumin

Clària J.

Roger Williams Seminar Series 2024, 18 June 2024, London, UK.

The lipid mediator landscape associated with infection and organ failure in patients with advanced liver disease

Romero-Grimaldo B, de la Peña-Ramirez C, Duran-Güell M, Contreras BJ, Sánchez-Rodríguez MB, Aguilar F, Clària J, López-Vicario C.

9th European Workshop on Lipid Mediators (9EWLM), 26–28 June 2024, Edinburgh, UK.

The linoleic acid-derived leukotoxin 9,10-diHOME drives immunosuppression in patients with acute-on-chronic liver failure

Contreras BJ, López-Vicario C, Casulleras M, Duran-Güell M, Romero-Grimaldo B, Trebicka J, Clària J.

9th European Workshop on Lipid Mediators (9EWLM), 26–28 June 2024, Edinburgh, UK.

Albumin reprograms the B cell transcriptional landscape and rescues neutrophil dysfunction in immunocompromised patients with advanced cirrhosis

Clària J, Aguilar F, Lozano JJ, Jiménez-Gracia L, Nieto JC, Romero-Grimaldo B, Marcos-Fa X, Giarracco E, Weiss E, Trebicka J, Hernàndez I, Fernandez J, Casulleras M, López-Vicario C, Muldur S, Hopke A, Vlagea A, Aransay AM, Marchese D, Bernardi M, Jalan R, Angeli P, Magri G, Cerutti A, Irimia D, Heyn H, Arroyo V, Moreau R.

The Liver Meeting 2024, American Association for the Study of Liver Diseases (AASLD), San Diego, CA, USA, 15–19 November 2024.

Intravenous administration with the ASK1 inhibitor SRT-015 alleviates liver injury and systemic inflammation in disease models of liver failure

Legry V, Malysiak M, Poulain P, Daix V, Hanf R, Hum D, Staels B, Clària J, Sayah-Jeanne S.

The Liver Meeting 2024, American Association for the Study of Liver Diseases (AASLD), 15–19 November 2024, San Diego, CA, USA.

Mitochondrial dysfunction in chronic liver disease

Clària J.

Mitochondria and Metabolism in Health and Disease, 10th Annual MetNet International Meeting, 25 October 2024, Barcelona, Spain.

The emerging role of lipids as drivers of systemic inflammation and organ failure in advanced liver disease

Clària J.

64th International Conference of the Bioscience of Lipids (ICBL), 15–18 October 2024, Taipei, Taiwan.

Typical triggers of multiorgan dysfunction in ACLF

Fernández J.

Intensive care in hepatology 2024: Advances and best practices, Endresprojects, 6 September 2024, Bern, Switzerland.

Design and status of PRECIOSA

Fernández J.

Special session on liver cirrhosis and ascites, China Liver Health (CLH), 25 August 2024, this event was held online.

Novel insights into the role of lipid mediators in chronic liver disease

Clària J.

9th European Workshop on Lipid Mediators (9EWLM), 27 June 2024, Edinburgh, UK.